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Abstract Ancient pathways of an apoptosis-like cell
death have been identified in unicellular eukaryotes
including protozoan parasites. Here, we examined pro-
grammed cell death in the apicomplexan Toxoplasma
gondii which is a common intracellular pathogen of
humans and warm-blooded animals. Treatment of extra-
cellular T. gondii with various pro-apoptotic stimuli sig-
nificantly induced DNA strand breaks as revealed by
TUNEL and flow cytometry. Using staurosporine or mil-
tefosine as pro-apoptotic stimuli, parasites also presented a
reduced cell size, i.e. pyknosis and externalized phospha-
tidylserine while the plasma membrane remained intact.
Importantly, staurosporine also induced DNA strand breaks
in intracellular T. gondii. Data mining of the Toxoplasma
genome resource identified 17 putative cell death-associ-
ated genes encoding proteases, a nuclease and several
apoptosis regulators. Staurosporine-treated parasites but
not controls strongly up-regulated several of these genes in
a time-dependent fashion with a putative PDCD2 protein
being more than 100-fold up-regulated. However, the
mitochondrial membrane potential (DWm) remained intact
and caspase-like activity increased only slightly during
staurosporine-triggered cell death. As compared to
staurosporine, the transcriptional response of parasites to
miltefosine was more restricted but PDCD2 was again
strongly induced. Furthermore, T. gondii lost their DWm
and rapidly presented strong caspase-like activity during
miltefosine treatment. Consequently, protease inhibitors
abrogated miltefosine-induced but not staurosporine-
induced Toxoplasma cell death. Finally, toxoplasmacidal
drugs triggered DNA strand breaks in extracellular
T. gondii. Interestingly, clindamycin also induced markers
of an apoptosis-like cell death in intracellular parasites.
Together, the data indicate that T. gondii possesses ancient
apoptosis-like cell death machinery which can be triggered
by chemotherapeutic agents.
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Introduction
Apoptosis is a form of programmed cell death (PCD) that
until recently was thought to be confined to metazoans. A
form of cellular suicide in single-celled organisms indeed
appeared counter-intuitive and evolutionary not favorable.
This view has been challenged with the detection of
markers that are characteristic for apoptosis in metazoans
in several unicellular organisms including protozoan par-
asites [1]. Signs of apoptosis have been recognized in
parasites from such different phylogenetic branches as the
kinetoplastids, the apicomplexans, the amoebozoa, Blas-
tocystis, the trichomonads and the diplomonads suggesting
an ancient origin of death-regulating genes during the
evolution of eukaryotes [2–4]. Hallmarks of apoptosis in
these organisms include shrinkage and rounding-up of the
cell, externalization of phosphatidylserine (PS) from the
inner to the outer leaflet of the cell membrane while
maintaining membrane integrity, and DNA fragmentation
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as well as chromatin condensation [1]. In silico analysis of
genome databases of various protists [5] and evolutionary
considerations [2, 3, 6] also argue for the existence of
ancient PCD pathways in unicellular organisms. Although
apoptosis-like cell death in protozoa shares several char-
acteristic features of apoptosis in metazoans, the underly-
ing mechanisms clearly differ. For example, cysteine
peptidases with specificity for aspartate, i.e. caspases, are
key players of apoptosis in higher eukaryotes but are not
present in the genomes of protists [5]. Likewise, members
of the Bcl-2 family which sense and integrate pro-apoptotic
signals into the mitochondrial apoptotic pathway in
mammals are absent from protozoa. Thus, the pathways
that regulate the demise of protozoa differ from those
present in mammals. This makes apoptosis in protozoa
a promising target for the development of novel inter-
vention strategies against parasites of medical and veter-
inary importance.
Toxoplasma gondii is an obligatory intracellular parasite
of the phylum Apicomplexa. It is ubiquitously distributed
and infects warm-blooded wild and domestic animals as
well as up to 30 % of the worlds’ human population [7].
Following infection, rapidly replicating tachyzoites infect a
variety of different cell types and disseminate throughout
their host leading to the acute phase of infection. Although
infection of immunocompetent hosts is usually benign to
asymptomatic, the parasite is not eradicated by the hosts’
immune defense. It instead transforms into the dormant
bradyzoite stage which is able to persist for the hosts’ life
span within intracellular cysts mostly within neural and
muscular tissues [8]. In immunocompromised hosts, i.e.
AIDS patients or transplant recipients, primary infection
or—more commonly—reactivation of persistent infection
can lead to life-threatening toxoplasmosis due to uncon-
trolled parasite replication and tissue damage [9]. Like-
wise, after vertical transmission of the parasite during acute
infection of pregnant women to their offspring, uncon-
trolled parasite replication can lead to congenital toxo-
plasmosis ranging from stillbirth to severe symptoms at
birth or sequelae including retinochorioiditis or mental
retardation. Ocular toxoplasmosis can also result from
postnatal infection, and T. gondii has been recognized as
the most common pathogen leading to posterior uveitis in
immunocompetent patients [10].
Chemotherapy of symptomatic toxoplasmosis is man-
datory; however, available drug regimens including pyri-
methamine plus sulfadiazine, clindamycin, and atovaquone
are limited and are only effective against the replicating
tachyzoite stage [9]. Furthermore, side effects of the
available drug treatments are common, and treatment
failures have been reported which may result from strain-
specific differences in susceptibility [11]. Thus, the
development of novel drugs against toxoplasmosis is
critical, as is a better understanding of molecular pathways
which regulate cell death in T. gondii.
In previous studies we have extensively characterized
the ability of intracellular T. gondii parasites to inhibit
apoptosis of its host cell [12–14]. In these studies we rec-
ognized the occurrence of extracellular parasites which
were positive for DNA strand breaks as determined by
terminal deoxynucleotidyl transferase-mediated dUTP nick
end labelling (TUNEL) (Lu¨der, unpublished observation),
i.e. a widely used marker for apoptotic cells [15]. This
prompted us to investigate whether and to what extent
apoptosis-like cell death occurs in T. gondii under different
environmental conditions and how this might be regulated.
Our results show that extracellular and intracellular para-
sites undergo a form of programmed cell death that share
several common features with metazoan apoptosis. In silico
analysis and biochemical data revealed components of
apoptosis-like cell death pathways in T. gondii that were
triggered by common pro-apoptotic stimuli. Finally we
present evidence that apoptosis-like cell death can be
triggered in intracellular parasites under clindamycin
treatment. Together, the results raise the intriguing possi-
bility that apoptosis-like cell death pathways can be
employed in order to combat toxoplasmosis.
Materials and methods
Parasites, in vitro cultivation and induction of cell death
The mouse-avirulent type II T. gondii strain NTE [16] was
used for all experiments. Parasites were propagated in
L929 murine fibroblasts as host cells; co-cultures were
cultivated in Roswell Park Memorial Institute (RPMI) 1640
medium supplemented with 1 % heat-inactivated fetal
bovine serum (FCS), 100 U/ml penicillin and 100 lg/ml
streptomycin. For infection assays, human foreskin fibro-
blasts (HFF) were used as host cells, and they were culti-
vated in Dulbecco’s Modified Eagle Medium (DMEM)
supplemented with 10 % FCS, 1 mM sodium pyruvate,
non-essential amino acids and antibiotics as above. Cells
were grown at 37 C in a humidified 5 % CO2 atmosphere.
For induction of cell death in extracellular parasites or for
infection assays, parasites were isolated from L929 co-
cultures by differential centrifugation and thoroughly
washed [12]. Briefly, host cells were pelleted by centrifu-
gation at 359g for 5 min. The supernatant was then cen-
trifuged at 1,3509g for 10 min, the parasites were washed
twice, resuspended in culture medium and counted in a
hemocytometer grid. For induction of cell death, 2 9 107
parasites were seeded in 0.5 ml of culture medium and
were treated for up to 72 h with 5–10 lM staurosporine,
20 lM miltefosine, 2 mM H2O2, or 5 lM camptothecin
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(all chemicals from Sigma-Aldrich, Taufkirchen, Ger-
many). Alternatively, 105 parasites per well were used to
infect confluent HFF cells that were grown in 24-well
plates containing cover slips. Twenty-four hours after
infection, infected HFF cells were treated with 10 lM
staurosporine or 20 lM miltefosine for 3–48 h. In some
experiments, 100 lM Z-VAD-FMK (Enzo Life Sciences,
Lo¨rrach, Germany) or 100 lM E64 (Sigma-Aldrich) were
added 1 h prior to the treatment with pro-apoptotic stimuli.
Treatment of T. gondii with parasiticidal drugs
HFF monolayers were infected as described above. After
removal of extracellular parasites at 4 h post infection,
infected cells were incubated for 24 and 48 h in medium
containing 100 nM atovaquone, 500 nM clindamycin, 1 lM
pyrimethamine or 500 nM anisomycin (all from Sigma-
Aldrich). Since clindamycin exerts toxoplasmacidal activity
during the second round of intracellular replication [17],
parasites that emerged from the drug-treated cells within
3–4 days p.i. were centrifuged at 1,5009g for 10 min, and
25 % of the parasites were used to infect fresh HFF cells in the
continuous presence of clindamycin (2nd cycle of treatment).
TUNEL assay and flow cytometry
DNA strand breaks were detected in freshly isolated
T. gondii parasites and those treated with pro-apoptotic
stimuli or the vehicle alone (mock treatment) using a ter-
minal deoxynucleotidyl transferase-mediated dUTP nick
end labelling (TUNEL) assay as recommended by the
manufacturer (Roche, Mannheim, Germany). After har-
vesting the parasites by centrifugation at 1,8009g for 10
min, they were washed in PBS, pH 7.4, and were then fixed
in 4 % (w/v) paraformaldehyde in 0.1 M sodium caco-
dylate, pH 7.4 for 1 h at room temperature. After having
been washed, the cells were permeabilized for 5 min with
0.1 % Triton X-100 in 0.1 % sodium citrate. They were
then centrifuged (as above) and were incubated in TUNEL
reaction mix containing fluorescein-conjugated dUTP and
terminal deoxynucleotidyl transferase for 1 h at 37 C in
the dark. Thereafter, cells were washed in PBS and were
analysed in a FACSCalibur flow cytometer (BD Biosci-
ences, San Diego, CA, USA). A total of 50,000 cells were
recorded from each sample.
Phosphatidylserine exposure
Translocation of phosphatidylserine from the inner to the
outer leaflet of the plasma membrane of T. gondii was
detected using the Annexin V-PE apoptosis detection kit
(BD Biosciences, Heidelberg, Germany). Parasites were
harvested by centrifugation (see above), were washed twice
in ice-cold PBS, and 1 9 106 parasites/ml were then
resuspended in 19 Annexin V binding buffer. After addi-
tion of 5 ll of Annexin V solution and/or 5 ll of 7-AAD
solution per 100 ll, cells were incubated for 15 min at
room temperature in the dark. Thereafter, 400 ll of 19
Annexin V binding buffer were added, and 10,000 cells of
each sample were analysed by FACS (FACSCalibur).
Unstained cells, cells stained with Annexin V alone, and
cells stained with 7-AAD alone were used as controls to
adjust channel compensation.
Determination of mitochondrial membrane potential
(DWm)
In order to determine the DWm, extracellular parasites were
harvested by centrifugation, were washed and were then
incubated in 500 nM MitoTracker probe Orange CM-
H2TMRos (Life Technologies/Molecular Probes, Darms-
tadt, Germany) in RPMI 1640 for 45 min at 37 C. After
having been washed in PBS, cells were fixed in 4 %
paraformaldehyde, 0.1 M sodium cacodylate, pH 7.4 for
15 min. Parasites were embedded in Mowiol 4-88 mount-
ing medium (Calbiochem, Schwalbach, Germany) and at
least 500 cells of each sample were examined by using a
Leica TCS SP2 confocal laser scanning microscope.
Detection of caspase-like activities
CaspaTagTM pan-caspase in situ assay kit (Chemicon/
Millipore, Schwalbach, Germany) was used to detect the
activity of caspase-like proteases during cell death induc-
tion in T. gondii. To this end, extracellular parasites were
incubated in the presence of 10 lM staurosporine or
20 lM miltefosine for 2, 4, 24 and 48 h to induce cell
death or were left untreated. At indicated time points,
treated parasites or freshly isolated ones were mixed with
fluorescein-conjugated FAM-VAD-FMK (FLICA reagent)
for 1 h at 37 C. After having been washed three times
with washing buffer, parasites were analysed by flow
cytometry (FACSCalibur).
Immunofluorescence staining, TUNEL assay
and fluorescence microscopy
DNA fragmentation in intracellular T. gondii or in isolated
parasites was morphologically visualized by double fluo-
rescence microscopy. Toxoplasma-infected HFF cells
grown on glass cover slips, or extracellular parasites which
had been spread onto glass slides and air-dried, were fixed
in 4 % (w/v) paraformaldehyde in 0.1 M sodium caco-
dylate, pH 7.4 for 1 h. Nonspecific binding sites were
blocked, and cells were permeabilized for 1 h in 0.1 mg/ml
saponin, 1 % bovine serum albumin (Sigma-Aldrich,
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Taufkirchen, Germany) in PBS (blocking buffer). After
having been washed in 0.1 mg/ml saponin in PBS, the cells
were incubated in rabbit anti-Toxoplasma hyperimmune
serum diluted in blocking buffer. After washing, immune
complexes were labelled for 1 h with 0.95 lg/ml Cy3-
conjugated donkey anti-rabbit IgG (Dianova, Hamburg,
Germany) in blocking buffer. Cells were washed again,
were treated with 0.1 % Triton X-100 in 0.1 % sodium
citrate for 5 min, and were then covered with TUNEL
reaction mix (in situ cell death detection kit, fluorescein;
Roche, Mannheim, Germany) for 1 h at 37 C in the dark.
In some experiments, parasite nuclei were additionally
stained for 45 min with 2 lg/ml Hoechst 33258 diluted in
saponin/PBS. After having been washed in PBS, cells were
mounted using Mowiol 4-88 and examined by confocal
laser scanning microscopy (Leica TCS SP2). For deter-
mining the extent of DNA fragmentation, at least 500
parasites per sample were inspected. Parasite replication
was determined by counting the number of tachyzoites of
at least 100 parasitophorous vacuoles.
RNA isolation and quantitative RT-PCR
Total RNA was extracted from 7 9 107 parasites treated or
not with pro-apoptotic stimuli using the GenEluteTM mam-
malian total RNA kit as recommended by the manufacturer
(Sigma-Aldrich). Contaminating DNA was digested by
using DNase 1 (amplification grade; Sigma-Aldrich). Up to
2 ug of mRNA were then reverse transcribed for 90 min at
37 C by oligodT priming using the Omniscript reverse
transcription kit (Qiagen, Hilden, Germany). Serial dilutions
of cDNA encoding for putative cell death regulators and
executors were amplified by quantitative real time PCR in a
capillary-based LightCycler system (Roche, Mannheim,
Germany) using the FastStart DNA MasterPLUS SYBR
Green I kit (Roche) and 0.25 lM each of the primers spec-
ified in Table 1. For 20 ll PCR reaction, the following
components were mixed: 2 ll of cDNA, 0.25 lM of forward
and reverse primers, 4 ll of buffer and enzyme mixture
(LightCycler FastStart DNA MasterPLUS SYBR Green I,
Roche Applied Science, Germany). The relative gene
expression levels were calculated as the fold change between
freshly isolated (control) and treated (staurosporine, mil-
tefosine, or mock-treatment) T. gondii using the formula
Normalized ratio(treated/freshly) = (Etarget)
DCP(freshly-treated)/
(Eactin)
DCP(freshly-treated), where amplification of actin was
used to normalize between the different samples and target
were putative cell death-associated genes.
Statistical analysis
Results are expressed as mean ± SEM of at least three
independent experiments unless otherwise stated.
Significant differences between experimental groups were
identified by Student’s t test. P values of less than 0.05
were considered significant.
Results
In situ DNA fragmentation in T. gondii
DNA fragmentation is one of the common biochemical
downstream hallmarks of apoptosis in mammals [18] and is
considered an important marker for apoptosis-like cell
death in protozoa [1]. In situ TUNEL labelling and flow
cytometry revealed that a population of freshly isolated
T. gondii contained *20 % of TUNEL-positive parasites
and this did not significantly change within the next 48 h
(Fig. 1). Treatment of T. gondii with H2O2, which triggers
apoptosis in mammalian cells, yeast and protozoa [19–22],
augmented the percentage of TUNEL-positive parasites
moderately (Fig. 1a, b) (p \ 0.05, Student’s t test), indi-
cating that oxidative stress may promote cell death in
T. gondii. Remarkably, the protein kinase inhibitor stauro-
sporine and the leishmanicidal alkylphosphocholine drug
miltefosine (HePC) strongly induced DNA fragmentation
in 50 and 57.5 % of parasites, respectively (Fig. 1a, b)
(p \ 0.0005). The ATP analog staurosporine is a highly
potent and widely used stimulus of cell-intrinsic apoptotic
pathways [23]. Likewise, miltefosine exerts pro-apoptotic
activity against cancer cells and Leishmania spp., possibly
via perturbation of fatty acid and sterol metabolism,
mitochondrial dysfunction and/or inhibition of the Akt/
PKB pathway [24]. Camptothecin (CPT), a DNA topoiso-
merase I inhibitor, also triggered DNA fragmentation in
T. gondii (Fig. 1b) (p \ 0.05). In Leishmania spp., CPT
activates a cell death pathway via deregulation of the
mitochondrium [25], thus implying that also in T. gondii,
impaired mitochondrial function might trigger a cell death
pathway which finally leads to DNA fragmentation.
Due to their well-established pro-apoptotic activities and
the strong induction of DNA fragmentation in T. gondii
(see above), we concentrated on staurosporine and mil-
tefosine in the following experiments. Kinetics of DNA
fragmentation revealed a time-dependent increase in the
percentage of TUNEL-positive parasites from 24 h
onwards until 72 h post staurosporine treatment (Fig. 1c).
Furthermore, staurosporine triggered DNA strand breaks in
a dose-dependent manner (Fig. 1c). Following treatment
with miltefosine, a significant increase in DNA fragmen-
tation was already observed at 24 h post treatment and
reached a plateau at 48 h (Fig. 1d).
Confocal laser scanning microscopy of extracellular
T. gondii which had been labelled using parasite-specific
antibodies and a TUNEL reaction mix confirmed the
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Table 1 Primers for quantitative real time PCR of T. gondii putative cell death-related cDNAs
Gene ID Forward (50–30) Reverse (50–30) Amplicon (bp)
TgME49_008710 AGGCAGCGAAACACAGAAAG ACATGCAGGGAAGCTCCA 264
TgME49_007620 CGCGTACCCATACGTGAAGA GCGACGAACTGTTGCTTGTC 234
TgME49_078970 ACTTCGTCGCGTTTCACTTT ATGCAGTACGCATTGAGCAG 248
TgME49_053000 AAGGCGAGAGGAATGGATTT CGTCGTAAAATTGCAGCAGA 201
TgME49_094420 AGAGAGGAGGGAGACGAAGG CAGCGAACTGTGTTCGTCAT 156
TgME49_093820 GACGATTCACACATGGTTGC TTGATTTTCCTGGGAGAACG 228
TgME49_093830 GACCTCTCGGCTGTAGCATC CGCACCGTCTGTCAGAGTTA 158
TgME49_021360 CTTCGTCAGCGGGAATATGT GCCGATAGTGAGTTGGGTGT 241
TgME49_049770 GCCATTGTTCCACGTCTTTT GAAGGGGAAGGAAGGAGATG 162
TgME49_109560 CCAGGACAATTTGCACACAC CGTCCGCTCTTTTCTTTACG 232
TgME49_003030 CCAGGCTGCTACTCCTTACG GAACCCGTTTCAATGTCGAT 171
TgME49_105490 TCTTGCCAGCGTGAATACTG GCGCTGATAGTCACTCCACA 247
TgME49_105870 GATGCATTCTGTGCGTGTCT GGGACTCACCTGGATTCTGA 159
TgME49_035560 TCCCAGTCCACAGAGTTCCT AGAGACGGCAAAGGATCAGA 209
TgME49_107780 GTTGCTGGGATAGCTTCTGC GCCTTGAGAGGACAGAGGTG 240
TgME49_035880 CCGAGCGAAGTTTTTACGTC CACCGAAAATGTGAGACACG 170
TgME49_006490 TTCGTCCACTACGCTTGTTG GGGAGAATCGTTTCGTCGTA 207
TgME49_009030 (actin) TGGCAACGAGCGATTCCGCTG GTTCCTTGGTCAGCCTCTCGCC 200
Fig. 1 Pro-apoptotic stimuli trigger DNA fragmentation in T. gondii.
Parasites were treated with hydrogen peroxide (H2O2), staurosporine
(Stau), miltefosine (HePC) or camptothecin (CPT) as indicated, or
were mock-treated. At different time points after treatment, DNA
strand breaks were visualized by in situ TUNEL labelling and
parasites were analysed by flow cytometry. Freshly isolated parasites
were processed in parallel (0 h). a Parasites were selected according
to FSC/SSC parameters and were analysed for terminal deoxynu-
cleotidyl transferase-mediated dUTP nick end labelling (TUNEL).
The graphs show representative histograms from parasites which
have been treated with the indicated stimuli for 48 h (open
histograms), or those which have been freshly isolated (filled
histograms). b Mean percentages ± SEM of TUNEL-positive
T. gondii as determined by flow cytometry; results are from 5 to 6
independent experiments (CPT: n = 2). Significant differences
between treated T. gondii and untreated controls are indicated by
one (p \ 0.05) or two asterisks (p \ 0.01). c, d Kinetics of DNA
fragmentation in T. gondii following treatment with staurosporine or
miltefosine or following mock treatment. Data represents mean ±
SEM from at least three independent experiments
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increase in TUNEL-positive parasites following treatment
with staurosporine and miltefosine as compared to freshly
isolated controls and mock treated controls (Fig. 2a). Both
the size and position of the TUNEL-reactive structures
were compatible with staining of the parasite nuclei
(Fig. 2a, b). By using the nuclear dye Hoechst 33258, we
confirmed that TUNEL-positive organelles in parasites
which had been treated with a pro-apoptotic stimulus co-
localized with the parasite nuclei (Fig. 2c; arrows). TUNEL-
positive parasites were mostly round-shaped and smaller
than the regular TUNEL-negative crescent-shaped parasites
(Fig. 2a, b). Both rounding-up of the cell and reduction of the
Fig. 2 DNA strand breaks and morphology of T. gondii following
treatment of extracellular (a–c) or intracellular (d) parasites with pro-
apoptotic stimuli and in situ TUNEL labelling. Parasites were treated
with staurosporine (Stau), miltefosine (HePC), or were mock-treated
for 3, 6 or 48 h as indicated, or were left untreated (0 h). After
labelling with anti-Toxoplasma serum (red fluorescence) and DNA
strand breaks using a terminal deoxynucleotidyl transferase-mediated
dUTP nick end labelling (TUNEL; green fluorescence), cells were
examined by confocal laser scanning microscopy. Differential
interference contrast (DIC) images were recorded to verify the
morphology of extracellular parasites (b) or to confirm the
localization of intracellular parasites (d). Arrowhead and arrow in
d indicate a TUNEL-positive intracellular parasite after mock-
treatment and a TUNEL-positive host cells after Stau treatment,
respectively. Data indicate the percentage of parasitophorous vacu-
oles containing TUNEL-positive parasites. Partially, parasite nuclei
were visualized in parallel using the nuclear dye Hoechst 33258 (blue
fluorescence) and conventional fluorescence microscopy (c). Arrows
in c indicate co-localization of TUNEL-positive organelles with
parasite nuclei. Representative micrographs from three independent
experiments are depicted
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cell volume are characteristic features of cells undergoing
apoptosis [18].
Due to the parasites’ intracellular life style, we then
tested whether T. gondii within its natural environment also
shows signs of apoptosis upon treatment with pro-apoptotic
stimuli. To this end, parasite-infected HFF cells were
treated with staurosporine or miltefosine for various time
periods. Remarkably, treatment with staurosporine for
3–6 h induced significant levels of DNA strand breaks in
intracellular parasites as determined by TUNEL assay
(44.3 and 48.9 % at 3 and 6 h after treatment, respectively;
Fig. 2d). Due to the induction of apoptosis in the host cells
(Fig. 2d, arrow), we were not able to follow up induction of
DNA strand breaks in T. gondii beyond 6 h of treatment.
TUNEL-positive intracellular parasites were not regularly
detected in mock-treated cells; however, it is interesting to
note that occasionally, we also observed DNA strand
breaks in intracellular control parasites (Fig. 2d, arrow-
head). Miltefosine did not induce DNA strand breaks in
intracellular parasites (0.6 and 0.5 % at 3 and 6 h after
treatment, respectively). Collectively, these data estab-
lished that treatment of both extracellular and intracellular
T. gondii with well-known pro-apoptotic stimuli induces
significant levels of DNA fragmentation, i.e. a hallmark
of apoptosis. We also provide compelling evidence that
extracellular T. gondii parasites are highly vulnerable to
miltefosine, a drug that at least partly exerts its activity by
triggering apoptosis.
Toxoplasma gondii displays multiple markers
of apoptosis after treatment with pro-apoptotic stimuli
Besides DNA fragmentation, a reduction in cell volume
(pyknosis) is a typical marker for apoptosis [18] and has
also been extensively applied for detecting apoptotic pro-
tozoa [1]. Using flow cytometry, we therefore determined
the cell size of T. gondii following treatment with pro-
apoptotic stimuli. The results showed a time- and con-
centration-dependent decrease of the mean forward scatter
(FSC) value following treatment of parasites with stauro-
sporine (Fig. 3a). Miltefosine led to a decrease of the
parasite cell size which was even more pronounced and
occurred more rapidly than after staurosporine treatment
(Fig. 3b). This time course was thus consistent with the
stronger and accelerated induction of DNA strand breaks
after treatment of T. gondii with miltefosine than after
treatment with staurosporine (Fig. 1c, d).
We also determined the externalization of phosphati-
dylserine (PS) from the inner to the outer leaflet of the
plasma membrane following treatment of T. gondii with
Fig. 3 Features of apoptotic-like cell death in T. gondii. Parasites
were treated with staurosporine (Stau) or miltefosine (HePC), or were
mock-treated for the indicated periods of time. a, b Parasites were
FACS-analysed and the mean forward scatter value was recorded as a
relative measure of the cell size. Data represents mean ± SEM from
at least three independent experiments. c–e Alternatively, parasites
were labelled with Annexin V and 7-AAD to detect those which
expose PS on their cell surface or those with a disrupted plasma
membrane, respectively. They were then FACS-analysed; an
unstained control was run in parallel. Two-dimensional dot plots
from a representative experiment are depicted, percentages of single
or double positive parasites are indicated (c). Mean percent-
ages ± SEM of Annexin V?, 7-AAD- (d) or 7-AAD? parasites
(e) were calculated from four independent experiments, significant
differences between experimental groups are indicated (p \ 0.01)
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pro-apoptotic stimuli. To this end, parasites were labelled
with Annexin V and 7-AAD in order to distinguish between
apoptotic and necrotic cells. The results showed that *5 %
of untreated parasites displayed PS on their plasma mem-
brane suggesting some basal level of parasites undergoing an
apoptosis-like cell death. Importantly, the percentages of
Annexin V?, 7-AAD- parasites clearly increased following
treatment with staurosporine or miltefosine for 24 h as
compared to mock-treated controls (Fig. 3c, d; p \ 0.01,
Student’s t test). This indicated the appearance of early
apoptotic cells displaying PS on the cell surface but with an
intact cell membrane. Between 24 and 48 h of treatment, the
percentages of Annexin V?, 7-AAD- parasites did not fur-
ther increase but were again clearly higher as compared to
mock-treated controls. During the time of observation, we
observed only a minor increase in the percentages of
7-AAD? cells after miltefosine treatment thus excluding a
prominent induction of necrosis in T. gondii treated with
staurosporine or miltefosine (Fig. 3c, e). Together, the data
strongly suggested that following treatment with pro-apop-
totic stimuli, T. gondii can undergo a form of programmed
cell death that shows characteristic features of apoptosis as
observed in metazoans.
Identification of putative programmed cell death
regulators in the T. gondii genome database
Molecules which might be involved in the regulation of an
apoptosis-like cell death in T. gondii are yet unknown. In
order to identify putative cell death regulators and executors,
we performed a genome-wide in silico search of the Toxo-
plasma resource database (ToxoDB; Version 6.3) [26] for
putative cell death-related genes. By employing a text-cen-
tered search approach, we identified 17 different T. gondii
(strain ME49) genes with evidence of PCD-associated
functions based on electronic annotation (Table 2). Genes
retrieved in this manner encoded for proteins with sequence
similarities to known or supposed regulators or executors of
an apoptosis-like cell death in other unicellular eukaryotes
including a putative endonuclease (TgME49_008710) [27,
28], several proteases including a putative metacaspase
(TgME49_0078970, TgME49_093820, TgME49_049770,
TgME49_006490) [29, 30], a defender against death (DAD)-
like protein (TgME49_105870) [31] and two programmed
cell death (PDCD) proteins (TgME49_094420, TgME49_
105490) [5]. The autophagy regulator beclin 1 (the mam-
malian homologue of yeast Atg6) was also identified in
T. gondii during this search (TgME49_021360) thus con-
firming the presence of an autophagy machinery [32] and
autophagic cell death in T. gondii [33, 34].
To further explore a possible role of the proteins in
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corresponding transcript levels following treatment of
extracellular parasites with staurosporine and miltefosine
by quantitative real-time RT-PCR. Transcripts of all 17
genes were detected in T. gondii and their expression did
not change in mock-treated parasites after 24 or 48 h as
compared to freshly isolated parasites (Fig. 4). In contrast,
following treatment with staurosporine, the majority of
mRNAs considerably increased in a time-dependent man-
ner. Transcripts which were most strongly up-regulated
encoded for a putative PDCD2 protein (TgME49_105490;
*100-fold up-regulated at 48 h), a putative ELMO and a
DNA/RNA endonuclease (both more than 20-fold), a
putative Fas apoptotic inhibitory molecule (*18-fold) and
two calpain-like proteins (both more than 10-fold)
(Fig. 4a). Transcripts of the putative PDCD2 protein
TgME49_105490 also strongly increased after miltefosine
treatment (more than 40-fold at 48 h), whereas others were
only regulated to a minor extent or not at all (Fig. 4b).
Together, the data suggest that T. gondii possesses ancient
PCD machinery, the expression of which is differentially
regulated during treatment with pro-apoptotic stimuli.
Regulation of apoptosis-like cell death in Toxoplasma
There is increasing evidence that mitochondria are not only
useful marker organelles for detection of apoptosis in
protozoa [1] but also play pivotal roles in the regulation of
cell death pathways of protists [25, 27–29, 35, 36].
Therefore, we determined changes of the mitochondrial
membrane potential (DWm) after treatment of T. gondii
tachyzoites with staurosporine and miltefosine. Mitochon-
dria from freshly isolated parasites readily accumulated the
MitoTracker probe thus indicating an intact DWm (Fig. 5a).
Following treatment with 10 lM staurosporine for 48 h,
the majority of parasites retained the DWm as also observed
in mock-treated parasites. However, treatment with 20 lM
miltefosine led to a loss of DWm in the majority of para-
sites (Fig. 5a). Time course analysis and enumeration of
Fig. 4 Transcript levels of putative PCD-related proteins after
treatment of T. gondii with pro-apoptotic stimuli. Parasites were
treated with staurosporine (Stau) or miltefosine (HePC), or were
mock-treated for 24 h (cross-hatched bars) and 48 h (black bars).
After RNA isolation and reverse transcription, cDNA was amplified
by quantitative real-time PCR using primers specific for putative cell-
death related genes and actin of T. gondii. Results are expressed as the
mean ratio (x-fold) ± SEM of the mRNA after treatment as compared
to freshly isolated, untreated parasites normalized to actin; data is
from three independent experiments
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DWm-positive cells revealed a significant decrease of par-
asites with functional mitochondria within 24 h of mil-
tefosine treatment (p \ 0.01; Student’s t test) with a further
decrease thereafter (Fig. 5b). In contrast, staurosporine and
mock treatments decreased the DWm by only 20 % and to a
similar extent (p [ 0.05). Thus, different cell death path-
ways appear to exist in T. gondii, one of which involves
loss of DWm.
Although protozoa do not express homologues of bona
fide caspases [5], metacaspases or caspase-like activities
have been recognized during PCD in several unicellular
eukaryotes [21, 29, 30, 37, 38]. Furthermore, a putative
metacaspase and several other proteases with possible
roles in PCD have been identified in the Toxoplasma
genome database (see above). We therefore tested the
possibility that caspase-like proteases might be activated
during cell death in T. gondii. In situ labelling of parasites
with a caspase inhibitor and FACS analysis revealed a
strong increase of binding within 2 h of miltefosine
treatment (p \ 0.001 as compared to mock-treated para-
sites; Student’s t test) (Fig. 6a, b). Such activity remained
high at 4 h after miltefosine treatment before declining
to control levels until 48 h post treatment. Staurosporine
also induced a significant (p \ 0.01) increase in caspase
labelling within 2 h of treatment as compared to mock-
treated controls (Fig 6a, b); however, inhibitor binding
was much lower when compared to that observed in
response to miltefosine and reached control levels already
at 4 h of treatment. Mock-treated control parasites did
not show any significant increase in caspase labelling
(Fig. 6a, b).
In order to corroborate an involvement of caspase-like
proteases in the miltefosine-triggered and staurosporine-
triggered apoptosis-like pathways in T. gondii, parasites were
pre-treated with cysteine protease inhibitor E64 or pan-cas-
pase inhibitor Z-VAD-FMK before induction of cell death
with staurosporine or miltefosine. As expected, treatment
with both pro-apoptotic stimuli in the absence of protease
inhibitors significantly increased the number of TUNEL-
positive parasites (p \ 0.05); however, in the presence of
E64 or Z-VAD-FMK, occurrence of miltefosine-triggered
DNA strand breaks was completely abolished (p \ 0.05)
(Fig. 6c). In contrast, both inhibitors did not significantly
inhibit staurosporine-triggered DNA strand breaks although
we observed a trend of E64 to partially reduce stauro-
sporine-induced DNA cleavage. Together, this data sug-
gests a distinct apoptosis-like cell death pathway in
T. gondii which involves mitochondrial loss-of-function
and caspase-like proteases and which is specifically acti-
vated by miltefosine but not staurosporine.
Fig. 5 Loss of mitochondrial membrane potential (DWm) during pro-
apoptotic treatment of T. gondii with miltefosine. Parasites were
treated with 10 lM staurosprine (Stau) or 20 lM miltefosine (HePC),
or were mock-treated for 24 and 48 h. Freshly isolated parasites and
treated parasites were incubated with MitoTracker probe Orange CM-
H2TMRos. After fixation, cells were analysed by confocal laser
scanning microscopy. a Representative images from three indepen-
dent experiments are depicted. b The percentages of cells with an
intact DWm were determined by counting at least 500 parasites per
sample; data represents mean ± SEM from three independent
experiments. Significant differences are indicated (**p \ 0.01)
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Apoptosis-like cell death following treatment
of T. gondii with parasiticidal drugs
In order to test the hypothesis that apoptosis-like cell death
might also play a role during chemotherapy of toxoplas-
mosis, T. gondii-infected human fibroblasts were treated
with common anti-parasitic drugs and then assayed for
occurrence of DNA strand breaks using TUNEL staining.
Concomitant immunofluorescence labelling of parasites
confirmed the significant reduction of parasite replication
following treatments of T. gondii with 500 nM anisomycin,
100 nM atovaquone or 1 lM pyrimethamine as compared
to the control treatment (p \ 0.01) (Fig. 7a). Due to its
delayed phenotype [17], 500 nM clindamycin effectively
inhibited parasite replication only during the second
(p \ 0.01) but not the first replication cycle (Fig. 7a). The
number of TUNEL-positive extracellular parasites
increased after treatment with all chemotherapeutics for
48 h as compared to the mock treatment with the strongest
increase being observed with atovaquone (p \ 0.05)
(Fig. 7b, c; marked by arrowheads in Fig. 7c). Remark-
ably, we also recognized a significant number of intracel-
lular parasites which were strongly TUNEL-positive during
the second cycle of clindamycin treatment (p \ 0.001)
(Fig. 7c, d; marked by arrows in Fig. 7c). Parasitophorous
vacuoles (PVs) containing such TUNEL-positive parasites
were found adjacent to PVs with TUNEL-negative para-
sites within the same host cell indicating a parasite-
autonomous execution of the cell death program (Fig. 7c).
In addition, they have lost their crescent shape and regu-
larly contained multiple TUNEL-positive structures
thereby resembling fragmented nuclei of mammalian cells
undergoing apoptosis. TUNEL-positive intracellular para-
sites were not or only very rarely found during the first
cycle of clindamycin treatment and during atovaquone
treatment, respectively (Fig. 7d). Our data thus indicate
that an apoptosis-like cell death can be triggered in extra-
cellular and intracellular parasites undergoing drug
treatment.
Discussion
The mechanisms of how protozoa including several major
pathogens of humans die are only recently being explored.
This is astounding since they promise insights into the
evolution of death pathways and may open up novel ave-
nues to combat infectious diseases of high impact on
Fig. 6 Activation of caspase-like proteases during pro-apoptotic
treatment of T. gondii. Parasites were treated with 10 lM stauro-
sporine (Stau) or 20 lM miltefosine (HePC), or were mock-treated
for up to 48 h, or were freshly isolated. a, b Parasites were stained
with a fluorescently labelled pan-caspase inhibitor (CaspaTag) and
analysed by flow cytometry. a Representative FACS histograms of
freshly isolated parasites or those treated for 2 h with pro-apoptotic
stimuli (open histograms) as compared to mock-treated parasites
(filled histograms). b Parasites were analysed at different time points
post treatment and the percentage of CaspaTag-positive cells was
determined. Data represents mean ± SEM from three independent
experiments; significant differences between groups treated with pro-
apoptotic stimuli or mock-treated are indicated (**p \ 0.01;
*p \ 0.05). c Parasites were treated with protease inhibitors E64 or
Z-VAD-FMK before being induced to undergo cell death with
staurosporine or miltefosine. After 48 h, DNA strand breaks were
visualized by TUNEL staining and positive cells were counted. Bars
represent mean ± SEM from three independent experiments and
significant differences are marked by asterisks (*p \ 0.05)
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human and animal health. Here we present several lines of
evidence that strongly suggest the existence of a form of
regulated cell death in the apicomplexan T. gondii that
resembles apoptosis of higher eukaryotes. First, common
markers of apoptosis including DNA strand breaks as
detected by TUNEL assay, externalization of phosphati-
dylserine, reduction in cell volume and rounding-up of the
cell were detected in the parasite. Second, Toxoplasma
death could be triggered by staurosporine, miltefosine,
hydrogen peroxide or camptothecin which also induce
apoptosis in metazoan and other protozoa. Third, using in
silico analysis of the Toxoplasma genome resource, we
identified 17 genes with annotated functions in pro-
grammed cell death and which were differentially expres-
sed following pro-apoptotic treatment of the parasite.
Finally, Toxoplasma could be completely rescued from
miltefosine-induced cell death by preventing the activation
of cysteine proteinases. We therefore propose a form of
cell death being present in T. gondii which—according to a
recent classification of cell death by the Nomenclature
Committee on Cell Death (NCCD)—resembles apoptosis
of metazoans [18] and which we propose to refer to as
apoptosis-like cell death. Besides the detection of several
common apoptosis markers in T. gondii, this term takes
Fig. 7 Toxoplasmacidal drugs can induce an apoptosis-like cell
death in extracellular and intracellular T. gondii. Parasite-infected
human fibroblasts were treated with 500 nM anisomycin, 100 nM
atovaquone, 1 lM pyrimethamine or 500 nM clindamycin or were
mock-treated. Clindamycin was applied during two consecutive
cycles of parasite replication. After 48 h of treatment, parasites were
immunofluorescently labelled (red fluorescence) and DNA strand
breaks were visualized by in situ TUNEL labelling (green fluores-
cence). a Parasite replication was assessed by counting the number of
parasites per 100 parasitophorous vacuoles (PV) and calculating the
average parasite number per PV. Bars represent mean ± SEM from
three independent experiments. b, d Extracellular (b) and intracellular
(d) parasites that were positive following TUNEL labelling were
counted; bars represent mean percentages ± SEM from three inde-
pendent experiments. c Representative micrographs of cells treated
with the indicated drugs for 48 h were obtained by confocal laser
scanning microscopy. Arrowheads indicate TUNEL-positive extra-
cellular parasites following atovaquone treatment and arrows indicate
TUNEL-positive intracellular T. gondii during the second cycle of
clindamycin treatment. Significant differences are marked by one
(p \ 0.05) or two asterisks (p \ 0.01)
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into consideration that molecular pathways which charac-
terize apoptosis in higher eukaryotes [39] only partially
overlap with those present in T. gondii. Our findings on an
apoptosis-like cell death in Toxoplasma are consistent with
previous reports on the occurrence of DNA fragmentation,
hypoploid nuclei and condensation of chromatin after
treatment of T. gondii with the nitric oxide donor sodium
nitroprusside [40]. They are also in line with the presence
of ancestral PCD pathways in several divergent branches of
unicellular eukaryotes including the Apicomplexa and an
early origin of PCD during evolution [2, 3, 5, 6].
A major question arising from our finding concerns
the functional significance of apoptosis-like cell death in
T. gondii. Toxoplasms in a distinct host are considered a
clonal population since they originate from a single inoc-
ulum transferred by ingestion of undercooked meat from a
chronically infected live stock or of oocysts shed by cats
into the environment [7]. In addition, sexual reproduction
only takes place in the intestinal epithelium of Felidae but
not in humans or other vertebrates. Finally, T. gondii
infection elicits a robust Th1-type immunity that allows
persistence of parasites from the primary infection but only
rarely those from a Toxoplasma super-infection. However,
as a population of genetically identical organisms in a
distinct host, the programmed cell death of a subpopulation
of parasites may be evolutionary sustainable because it
could help avoiding an overwhelming parasite load and
host death before parasite transmission would have been
possible [41]. This may be particularly important for
T. gondii the transmission cycle of which critically depends
on establishing a long-lasting chronic infection. A parasite
population exposing phosphatidylserine on the outer leaflet
of the plasma membrane has indeed been described in the
peritoneal fluid of mice during acute infection [42].
Although these parasites appeared to be TUNEL-negative
they are nevertheless reminiscent of apoptotic cells and
could have contributed to regulate the parasite density
during acute infection. Whether such suicide-mediated cell
death also regulates parasite numbers during chronic
infection awaits clarification. Furthermore, apoptosis-like
cell death and exposure of phosphatidylserine by T. gondii
has been reported to dampen the host immune response by
inducing TGF-b secretion, i.e. a mechanism known as
apoptotic mimicry [42, 43]. Future studies are, however,
clearly needed to more precisely determine the phenotype
of phosphatidylserine-exposing parasites from the perito-
neal cavity. Furthermore, the molecular mechanisms
leading to this phenotype are unknown.
Here, we present evidence that different apoptosis-like
cell death pathways were induced in T. gondii in response
to staurosporine and miltefosine treatments (Table 3). One
of these pathways involved a rapid and strong activation of
caspase-like proteases, a loss of the DWm, and high
expression levels of a putative member of the PDCD2
superfamily of pro-apoptotic regulators. Permeabilization
of the outer mitochondrial membrane (MOMP) is crucial in
integrating various upstream signals into the caspase
9-caspase 3/7 cascade in mammals but also into the release
of caspase-independent pro-apoptotic factors including
EndoG or AIF [44]. The DWm collapses shortly after
MOMP in various mammalian systems although its con-
tribution in promoting apoptosis is still controversial [45].
Dissipation of DWm has been linked to apoptosis-like cell
death in Leishmania and Trypanosoma parasites [29, 46–
48], and in the free-living slime mold Dictyostelium dis-
coideum [35] while its involvement in Plasmodium apop-
totic pathways is a matter of debate (reviewed in [1]). In
T. gondii, DWm was rapidly lost following miltefosine
treatment indicating mitochondrial dysfunction in dying
parasites. However, whether this is an essential step in the
regulation and execution of miltefosine-induced cell death
in T. gondii awaits future clarification. In contrast, cysteine
protease activity was clearly required during miltefosine-
induced cell death in T. gondii since E64 and Z-VAD-FMK
completely abolished drug-induced TUNEL positivity.
A critical role of caspase-like proteases in this pathway is
further supported by the strong increase of CaspaTag-
positive parasites within two hours of miltefosine treat-
ment. The CaspaTag assay used herein relies on binding of
a fluorochrome-labelled inhibitor of pan-caspases, FAM-
VAD-FMK, to activated caspases. However, VAD-FMK
does not exclusively bind bona fide caspases but also other
cysteine proteases including distinct cathepsins (i.e., clan
CA cysteine proteases) and legumain (belonging to clan
CD cysteine proteases, which also comprise caspases and
metacaspases) [49]. This explains the efficient binding of
VAD-FMK inhibitors in miltefosine-treated T. gondii
despite absence of an authentic caspase in the parasite
genome ([5] and our own bioinformatic analysis). Several
clan CA cysteine proteases including cathepsin B, L and C
proteases have been characterized in T. gondii and play
crucial roles in maturation of excretory/secretory proteins,
host cell invasion and replication [50–52]. A role in PCD
has not yet been reported for any of these proteins. In
our bioinformatic search, we identified several additional
proteases which might fulfil pro-apoptotic functions in
T. gondii including a metacaspase-1 (TgME49_006490), an
ICE-like protease (TgME49_078970) and several calpain-
type cysteine proteases (TgME49_093830, TgME49_
093820, TgME49_107780). Distinct mammalian calpains
regulate apoptosis (reviewed in [53]), and metacaspases
of some protozoan parasites have been implicated in PCD
[30, 37, 38]. It will thus be interesting to see whether one of
the newly identified PCD-related proteases of T. gondii
is responsible for the miltefosine-induced apoptosis-like
cell death.
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Another feature of miltefosine-induced Toxoplasma cell
death was the strong up-regulation of a putative PDCD2
family member (Table 3). Increased PDCD2 expression
can induce apoptosis in human cells, at least in part by
activating a caspase cascade, whereas repression of
PDCD2 is involved in the pathogenesis of certain human
lymphomas [54, 55]. It is evolutionarily conserved and has
been identified in all eukaryotes [5]. Here, we confirm that
it is also present in the Toxoplasma genome and—more
importantly—we show that it is strongly up-regulated in
response to pro-apoptotic stimuli. Pro-apoptotic treatment
of rat thymocytes increased the expression of Rp8, i.e. the
rat orthologue of PDCD2 and this preceded DNA frag-
mentation [56]. This supports the hypothesis that the pro-
apoptotic function of PDCD2 is transcriptionally regulated.
Whether its pro-apoptotic effect is due to repression of
gene transcription by interaction with N-CoR/mSin3A
corepressor complexes [57, 58] and/or activation of a
caspase cascade [55] remains to be clarified. In T. gondii,
up-regulation of PDCD2 did not correlate with activation
of caspase-like proteases, since staurosporine induced high
levels of PDCD2 mRNA but only a minor (though signif-
icant) and transient activation of caspase-like proteases. It
should be mentioned that PDCD2 in T. gondii, as in most
other unicellular eukaryotes [5], contains the C-terminal
PDCD2 domain (IPR007320) but not the N-terminal zinc
finger, MYND-type domain that is present in PDCD2 of
higher eukaryotes. In humans, the MYND domain of
PDCD2 interacts with cell cycle regulator host cell factor 1
(HCF-1) and presumably also with N-Cor/mSin3A com-
plexes [57, 58], but it is unknown whether these or other
interactions are required for the pro-apoptotic function of
PDCD2. Thus, despite the absence of MYND in PDCD2
from T. gondii, it can well be that it exerts pro-apoptotic
functions. However, the exact role and molecular mecha-
nisms of PDCD2 during cell death in T. gondii requires
further investigation.
Interestingly, high PDCD2 mRNA levels were also
observed after staurosporine treatment whereas—in con-
trast to the response to miltefosine—parasites retained an
intact DWm and showed considerably less caspase-like
activity (Table 3). It should be stressed that the intact
DWm does not exclude an involvement of mitochondria
in staurosporine-triggered apoptosis-like cell death in
T. gondii since loss of DWm is also not necessarily crucial
for MOMP in mammals [45] and for execution of apoptosis
in invertebrates [44, 59]. It nevertheless indicates clear
differences in the signalling pathways that are activated in
T. gondii in response to different pro-apoptotic stimuli.
This view is further sustained by a much more complex
transcriptional response to staurosporine as compared to
that observed in response to miltefosine. Thus, despite the
fact that apoptotic pathways in unicellular eukaryotes are
considered ancestral, they nevertheless appear to be highly
complex.
Here, we also present the first report that treatment of
T. gondii with drugs which are commonly used for che-
motherapy of toxoplasmosis, can induce a form of parasite
death that show signs of apoptosis. This finding is of major
interest because it opens up the possibility to target
endogenous cell death pathways of T. gondii in order to
combat toxoplasmosis. DNA strand breaks were most
strongly induced in extracellular parasites using the
hydroxy-naphthoquinone atovaquone which targets the
cytochrome bc1 complex thereby inhibiting the mitochon-
drial respiratory chain [60]. In contrast, atovaquone
induced only very low levels of DNA fragmentation in
intracellular parasites. Intriguingly, however, a significant
number of intracellular parasites showed signs of apoptosis
following treatment with the lincosamide clindamycin.
Clindamycin inhibits protein synthesis of the apicoplast, a
non-photosynthetic plastid of apicomplexan parasites [61],
by binding to rRNA of the large subunit [62]. Consistent
with the well-known delayed parasiticidal activity of
clindamycin ([17]; Fig. 7a), DNA fragmentation in intra-
cellular parasites only occurred during the second cycle of
replication and this coincided with a significant reduction
of the parasitic load. It should be mentioned that only a
minor portion of intracellular T. gondii presented signs of
apoptosis following clindamycin treatment. This is unlikely
due to local differences in drug concentrations since vac-
uoles with TUNEL-positive parasites were adjacent to
Table 3 Regulation of apoptosis-like cell death pathways in T. gondii triggered by pro-apoptotic stimuli
Staurosporine Miltefosine
Mitochondria Intact DWm Loss of DWm
Caspase-like activity Small but significant increase at 2 h Strong increase at 2 and 4 h
Protease inhibitors
(E64, zVAD)
No significant impact Prevention of cell death
Up-regulation of
mRNAs ([10-fold)





DNA strand breaks (TUNEL), PS exposure, no membrane
permeabilization, pyknosis, rounding-up of cell
DNA strand breaks (TUNEL), PS exposure, no membrane
permeabilization, pyknosis, rounding-up of cell
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vacuoles with TUNEL-negative parasites within the same
host cell. It may rather result from the fact that T. gondii is
particularly vulnerable to clindamycin during the late
stages of endodyogeny, i.e. the formation of two daughter
cells from the mother cell [62]. This would indicate the
induction of an apoptosis-like cell death by clindamycin
during distinct stages of parasite replication. Furthermore,
the additive effect of the drug during successive rounds of
the parasites’ lytic cycle [63] suggests that the number of
TUNEL-positive parasites may further increase during
prolonged drug treatment and may have been not detected
in our experiments until 48 h of the second cycle of
treatment. In summary, an apoptosis-like cell death can be
triggered in intracellular T. gondii by chemotherapeutic
agents that specifically target the parasite as shown herein.
Detailed knowledge of the apoptosis-like death pathway
induced by clindamycin and possible other parasiticidal
drugs might be exploited in the future to combat Toxo-
plasma and related parasites, e.g. the malaria parasite
Plasmodium more effectively.
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